Abstract
Dendrimers are monodisperse, regular, three-dimensional and small-scale macromolecules that can be used to release substances such as drugs, markers, and genetic material into the cells. Among these substances, nucleic acids such as plasmid DNA, antisense oligonucleotides (asODN), and small-interfering RNA (siRNA) are widely used as therapeutic macromolecules for the treatment and prevention of diverse diseases. Several studies were focused on the modification of dendrimers aiming to improve their affinity for nucleic acids and their ability to release nucleic acids inside the cells. However, high-generation dendrimers have been shown to provoke leaking of cell membranes due to high surface-charge density. Thereby, despite the high potential of dendrimers, cytotoxicity still represents a problem to be solved prior to future in-vitro and in-vivo applications. Many approaches have proposed the introduction of diverse functional groups in low generation dendrimers, to reduce potential surface-charge density, without a loss in the ability to interact with nucleic acids. Another issue that should be addressed is how to modulate the affinity of dendrimers for nucleic acids at different pH values to guarantee an adequate release of the cargo in endosomal vesicles. These questions may be addressed through the aid of computational chemistry and bioinformatics tools. Therefore, the present review aims to provide a detailed review focused on the several techniques that have been developed for the study and design of dendrimers as carriers for DNA or RNA.
Conclusions: As shown in the present review, molecular dynamics simulations can contribute by studying at theoretical level dendrimer-nucleic acid complexes at different conditions, such as pH or ionic strength. Therefore, different cell conditions such as the stay at the cytoplasm and the transit towards endosomes can be addressed. The influence of different terminal groups of dendrimers to DNA/RNA binding can also be evaluated using molecular simulations and especially, by using free energy methods, which aim to determine affinity of dendrimers for nucleic acids. The development of a library of terminal groups for dendrimers may represent a significant contribution to the design of new dendrimers. In this regard, protein-DNA interactions of structure databases have been analyzed as a way to identify suitable residues that can be incorporated as terminal groups of dendrimers. In summary, computational chemistry and biology tools will aim the design of new dendrimers for different kinds of cargo molecules.Keywords: Dendrimers, nucleic acids, transfection, molecular dynamics, free energy calculations, macromolecules.
Current Pharmaceutical Design
Title:Multiscale Molecular Simulations Applied to Nucleic Acid-Dendrimer Interactions Studies
Volume: 23 Issue: 21
Author(s): Valeria Márquez-Miranda*, Ingrid Araya-Durán and Fernando Danilo González-Nilo*
Affiliation:
- Universidad Andres Bello, Center for Bioinformatics and Integrative Biology (CBIB), Facultad de Ciencias Biológicas, Av. República 239, Santiago,Chile
- Universidad Andres Bello, Center for Bioinformatics and Integrative Biology (CBIB), Facultad de Ciencias Biológicas, Av. República 239, Santiago,Chile
Keywords: Dendrimers, nucleic acids, transfection, molecular dynamics, free energy calculations, macromolecules.
Abstract: Dendrimers are monodisperse, regular, three-dimensional and small-scale macromolecules that can be used to release substances such as drugs, markers, and genetic material into the cells. Among these substances, nucleic acids such as plasmid DNA, antisense oligonucleotides (asODN), and small-interfering RNA (siRNA) are widely used as therapeutic macromolecules for the treatment and prevention of diverse diseases. Several studies were focused on the modification of dendrimers aiming to improve their affinity for nucleic acids and their ability to release nucleic acids inside the cells. However, high-generation dendrimers have been shown to provoke leaking of cell membranes due to high surface-charge density. Thereby, despite the high potential of dendrimers, cytotoxicity still represents a problem to be solved prior to future in-vitro and in-vivo applications. Many approaches have proposed the introduction of diverse functional groups in low generation dendrimers, to reduce potential surface-charge density, without a loss in the ability to interact with nucleic acids. Another issue that should be addressed is how to modulate the affinity of dendrimers for nucleic acids at different pH values to guarantee an adequate release of the cargo in endosomal vesicles. These questions may be addressed through the aid of computational chemistry and bioinformatics tools. Therefore, the present review aims to provide a detailed review focused on the several techniques that have been developed for the study and design of dendrimers as carriers for DNA or RNA.
Conclusions: As shown in the present review, molecular dynamics simulations can contribute by studying at theoretical level dendrimer-nucleic acid complexes at different conditions, such as pH or ionic strength. Therefore, different cell conditions such as the stay at the cytoplasm and the transit towards endosomes can be addressed. The influence of different terminal groups of dendrimers to DNA/RNA binding can also be evaluated using molecular simulations and especially, by using free energy methods, which aim to determine affinity of dendrimers for nucleic acids. The development of a library of terminal groups for dendrimers may represent a significant contribution to the design of new dendrimers. In this regard, protein-DNA interactions of structure databases have been analyzed as a way to identify suitable residues that can be incorporated as terminal groups of dendrimers. In summary, computational chemistry and biology tools will aim the design of new dendrimers for different kinds of cargo molecules.Export Options
About this article
Cite this article as:
Márquez-Miranda Valeria *, Araya-Durán Ingrid and González-Nilo Danilo Fernando*, Multiscale Molecular Simulations Applied to Nucleic Acid-Dendrimer Interactions Studies, Current Pharmaceutical Design 2017; 23 (21) . https://dx.doi.org/10.2174/1381612823666170306093224
DOI https://dx.doi.org/10.2174/1381612823666170306093224 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Oral Hypoglycemics: A Review of Chemicals Used to Treat Type 2 Diabetes
Current Bioactive Compounds Local Physiological Regulation and Modern Treatments in Gynaecology
Current Women`s Health Reviews miRNA as Regulators of Prostate Carcinogenesis and Endocrine and Chemoresistance
Current Cancer Drug Targets Strategy of Cancer Targeting Gene-Viro-Therapy (CTGVT) a Trend in Both Cancer Gene Therapy and Cancer Virotherapy
Current Pharmaceutical Biotechnology Treating Age-Related Macular Degeneration – Interaction of VEGF-Antagonists with their Target
Mini-Reviews in Medicinal Chemistry Gamma-Amino Butyric Acid Inhibits the Nicotine-Imposed Stimulatory Challenge in Xenograft Models of Non-Small Cell Lung Carcinoma
Current Cancer Drug Targets mRNA as a Versatile Tool for Exogenous Protein Expression
Current Gene Therapy Expression of Estrogen-Regulated Genes During Development in the Mouse Uterus Exposed to Diethylstilbestrol Neonatally
Current Pharmaceutical Design The ARRONAX Project
Current Radiopharmaceuticals Particulate Systems Based on Poly(Lactic-co-Glycolic)Acid (pLGA) for Immunotherapy of Cancer
Current Pharmaceutical Design Targeting the BH3 Domain of Bcl-2 Family Proteins. A Brief History From Natural Products to Foldamers As Promising Cancer Therapeutic Avenues
Current Medicinal Chemistry The Role of Neuropeptide Processing Enzymes in Endocrine (Prostate) Cancer: EC 3.4.24.15 (EP24.15)
Protein & Peptide Letters Activation of p53 by Specific Agents in Potential Cancer Therapy
Current Medicinal Chemistry - Anti-Cancer Agents Bioactive Chromone Derivatives – Structural Diversity
Current Bioactive Compounds Furan-induced Oxidative Stress and DNA Damage in Diabetic and Nondiabetic Rats’ Blood and Protective Effect of Lycopene
Current Nutrition & Food Science Role of Androgen Receptor in Prostate Cancer Cell Cycle Regulation: Interaction with Cell Cycle Regulatory Proteins and Enzymes of DNA Synthesis
Current Protein & Peptide Science Involvement of the Mitochondrial Benzodiazepine Receptor in Traumatic Brain Injury: Therapeutic Implications
CNS & Neurological Disorders - Drug Targets Selective Acetyl- and Butyrylcholinesterase Inhibitors Reduce Amyloid-β Ex Vivo Activation of Peripheral Chemo-cytokines From Alzheimer's Disease Subjects: Exploring the Cholinergic Anti-inflammatory Pathway
Current Alzheimer Research (Neuro)Transmitter Systems in Circulating Immune Cells: A Target of Immunopharmacological Interventions?
Current Medicinal Chemistry Post-Translational Protein Modifications of Rare and Unconventional Types: Implications in Functions and Diseases
Current Medicinal Chemistry